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PREFACE 
The Frog Embryo Teratogenesis Ascay-Xenopus (FETAX) is an in 
vitro bioassay designed to determine the potential teratogenic risk a 
compound or mixture poses to developing organisms. The system utilizes 
embryos of the South African clawed frog, Xenopus laevis, in 96 
hour exposures to a solution of toxicant and evaluates malformation, 
mortality, and growth endpoints in order to determine the teratogenic 
risk of the compound. For this test system to be routinely used for 
assessing the developmental toxicity of chemical agents it must be 
standardized and validated. This work was conducted to increase 
acceptance of FETAX by refining and validating the assay and applying 
it to a variety of situations. It is hoped that the studies presented 
here will encourage scientists in both biomedical and environmental 
toxicology to use FETAX as a screening test for developmental 
toxicants. 
The three studies encompassing this research involved developing a 
defined medium for use in the assay, validating FETAX by comparing the 
toxicity and teratogenicity of several compounds in Xenopus embryos 
with that reported in mammalian tests, and evaluating metal 
contaminated sediments for developmental toxicity using both frog and 
fathead minnow embryos. A report on the results of each of the three 
studies has been accepted for publication. Chapter II has been 
published in the Journal of Applied Toxicology (Volume 7, pages 
Hi 
237-244, 1987); Chapter III was published in Teratology (Volume 35, 
pages 221-227, 1987); Chapter IV was scheduled for publication in the 
December, 1987 edition of Environmental Toxicology and Chemistry. 
Each of these chapters is presented in the format of the respective 
journal. 
This work could not have been done without the help of many people 
and I am grateful to all who assisted. Dr. John A. Bantle served as my 
major adviser. Dr. S.L. Burks, Dr. Calvin Beames, and Dr. David 
Francko served as advisery committee members. Dr. Lester Rolf and Dr. 
Ronald McNew also provided assistance with part of this work. The 
contributions of each of these faculty members is appreciated. 
Several students and technicians assisted in the performance of 
this research, including: Melanie Hopper, Debbie Newell, Doug Fort, and 
Steve Bell. The students and staff of the Water Quality Research 
Laboratory, directed by Dr. Burks, were also of great assistance. 
Special thanks are extended to Elaine Stebler, Curt McCormick, and 
Sarah Kimball. 
The work was supported by grant funding made available to Dr. 
Bantle by the University Center for Water Research at Oklahoma State 
University and the March of Dimes Birth Defects Foundation. The 
University Center f6r Water Research also provided support for this 
work through their Presidential Fellowship program in water resources. 
The assistance of Dean Durham and the UCWR staff is very much 
appreciated. 
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CHAPTER I 
INTRODUCTION 
Background 
Teratology is the study of abnormal structural development. 
During animal development, precisely regulated processes give rise to a 
complete multicellular organism. Many situations or events, such as 
exposure to chemical agents, may disrupt these normal processes leading 
to malformation. The effects of these chemicals may occur at 
concentrations far below that which induces general cytotoxicity, 
increasing the chance an exposed organism will be alive and malformed. 
The testing of chemical agents, especially drugs, for teratogenic 
hazard has been a focal point of teratological research ever •ince the 
1960's, when limb-reduction malformations in newborn children were 
correlated to the use of thalidodmide by pregnant women (Wilson, 1977). 
New compounds that are developed each year need to be specifically 
tested for potential teratogenicity to prevent similar occurences. 
Presently, teratogenesis testing involves the use of small mammals 
such as rats, mice, hamsters, or rabbits but primates may be used as 
well. These procedures are time-consuming and expensive and have 
become overtaxed by the increasing number of chemicals that need to be 
tested (Kimmel et al., 1982). To help reduce these problems many 
alternative test systems have been developed that may prove useful in 
prioritizing compounds for further mammalian testing (Best and Morita, 
2 
1982; Bournias-Vardiabasis and Teplitz, 1982; Fantel, 1982; Greenburg, 
1982; Jelinek, 1982; Johnson et al., 1982; Kochhar, 1982; Sadler et 
al., 1982; Schuler et al., 1982; and Dumont et al., 1983). One or more 
of these assays may eventually be used to directly predict the 
embryotoxic hazards an agent poses to humans (Kimmel et al., 1982). 
One system is the Frog Embryo Teratogenesis Assay-Xenopus 
(FETAX), developed by J.N. Dumont and T.W. Schultz at the Oak Ridge 
National Laboratory (Dumont et al., 1983). This assay utilizes embryos 
of the South African clawed frog, Xenopus laevis, to determine the 
relative teratogenic risk of a test compound or environmental 
contaminant. Several studies have indicated that FETAX is useful as an 
assay for detecting compounds or mixtures that may cause abnormal 
structural development (Browne and Dumont, 1979; Dumont and Schultz, 
1980; Davis et al., 1981; Courchesne and Bantle, 1985; Sabourin et al., 
1985; and Schultz et al., 1985). 
The overall objective of this dissertation research was to couple 
the development and validation of FETAX as a standard teratogenesis 
test with additional applications for aquatic toxicology research. To 
do this three areas of investigation were emphasized: refinement, 
validation, and applications for use. 
Refinement 
Reducing sources of variation in FETAX may ultimately determine 
the value of this system as a standard test method. By developing 
specific procedures to reduce variation and by standardizing the test 
protocol data comparison and interpretation can be facilitated •. One 
way to reduce variation was to develop a defined medium to be used by 
all FETAX researchers. This would provide a greater degree of quality 
3 
control necessary in standardized testing protocols. 
Several reconstituted water formulae were tested and the most 
promising was selected for further tests with validation compounds. 
This allowed a determination to be made on the use of the new solution 
as the standard medium for FETAX researchers. It was necessary to 
develop this solution early in the research program so that later 
research would benefit from the increased quality control. 
Validation 
Validation studies were needed to demonstrate that FETAX result 
were similar to the results of established mammalian tests (Kimmel et 
al., 1982; Smith et al., 1983). As many as 100 compounds may need to 
be tested to fully validate the assay. Validation of FETAX using one 
set of test chemicals has been partially completed (T.D. Sabourin, 
personal communication). In this research, further testing was 
conducted within time and cost restraints to more fully validate FETAX. 
Test compounds were chosen from several lists (Smith et al, 1983; 
Seidenberg et al., 1986; and Shepard, 1986) and included known human 
teratogens. Completed validation should demonstrate that FETAX is a 
system of choice for rapidly determining potential teratogenic hazards. 
The testing of validation compounds represents only a small portion 
of chemicals presently in use and does not consider the effects of 
compound interactions. Therefore, an additional method of validation 
was conducted based on two teratogenic interactions studies performed 
using mammalian systems (Ritter et al., 1982; Nakatsuka et al., 1983). 
In these studies a pattern of teratogenic potentiation (a more than 
additive effect) was apparent when methylxanthines were coadministered 
with inhibitors of DNA, protein, and nucleic acid synthesis. 
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Demonstration of a similar pattern of potentiation in Xenopus embryos 
would further validate the assay. Compound interactions can be tested 
more rapidly and economically using FETAX. Therefore, successful 
completion of this study would help increase acceptance of FETAX as a 
model system for studying the toxic and teratogenic effects of multiple 
compounds on developing organisms. 
Applications 
An important factor for eventual acceptance and use of FETAX will 
be the variety of practical situations to which it can be applied. 
Previous research has indicated that FETAX can be adapted to test water 
samples from contaminated sites in the environment (Dumont et al., 
1983; Dawson et al., 1985). Aqueous extracts of metal-contaminated 
sediment were tested using FETAX to further demonstrate the value and 
utility of the assay for environmental testing. The extraction 
procedure used was designed to enable researchers to determine the 
potential developmental toxicity that might be observed if metals were 
leached from aquatic sediments (McCormick, 1985). This study included 
testing of fathead minnow embryos as well to help demonstrate that the 
responses of Xenopus embryos were similar to those of other aquatic 
vertebrates. This would increase acceptance of Xenopus as a test 
organism for aquatic toxicology research and increase the use of FETAX. 
It was hoped that the study would clearly demonstrate that a 
malformation endpoint can provide-~aluable information to aquatic 
toxicologists, by assessing toxicant hazards during embryonic 
development. Early-life stages are a sensitive point in the life-cycle 
of aquatic organisms (Holcombe et al., 1982; Birge et al., 1985). A 
specific malformation endpoint is not presently used in most testing of 
5 
environmental samples. 
By not limiting this research to test compound validation, more was 
accomplished toward the primary goal of increasing the acceptance of 
FETAX as a standard test procedure. In focusing on these areas of 
refinement, validation, and applications of FETiL~, the assay may become 
more widely used for determining developmental hazards in biomedical 
and environmental research. 
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CHAPTER II 
DEVELOPMENT OF A RECONSTITUTED WATER MEDIUM AND 
PRELIMINARY VALIDATION OF THE FROG EMBRYO 
TERATOGENESIS ASSAY-XENOPUS (FETAX) 
Abstract 
A reconstituted water medium was developed for use in the Frog 
Embryo Teratogenesis Assay-Xenopus (FETAX). FETAX solution was then 
tested on three compounds with known mammalian teratogenicity (ethanol, 
caffeine, and 5-fluorouracil) as was a non-teratogen (saccharin). The 
results obtained were then compared with results from tests on these 
compounds in two other media that had previously been used in the 
assay. Saccharin was not teratogenic. Ethanol and caffeine were weak 
and mode.rate teratogens, respectively. 5-fluorouracil was a strong 
teratogen. The results compare favorably with those obtained in 
mammalian studies. The amount of growth inhibition in embryos in the 
96 h tests was positively correlated with the degree of teratogenicity 
of the compound. Final validation of FETAX will allow it to be used to 
screen and rank compounds for further testing and as a tool for 
studying the basic mechanisms of teratogenesis. 
9 
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Introduction 
Embryos of the South African clawed frog, Xenopus laevis, 
have been used to determine the toxic and teratogenic effects of; 
fungicides and herbicides, 1 chemicals, 2 heavy metals, 3 and 
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complex effluents. Similar studies by other researchers have made 
use of Xenopus and other amphibians. The Frog Embryo Teratogenesis 
Assay-Xenopus (FETAX) was developed by Dumont et a1. 5 and is 
presently being validated as a screening test to determine the 
teratogenic risk of chemical agents and polluted waters. 
Recent work in this laboratory has shown that the system has great 
potential for detecting the teratogenicity of individual compounds 6 
and complex mixtures. 7 Studies such as these are vital to the 
acceptance of FETAX as an acceptable method of teratogenic risk 
assessment. Successful validation of FETAX should allow the screening 
test to be used alone or in conjunction with other in vitro assay 
systems to rank compounds for further testing in mammals. Nationwide 
use of FETAX would allow for the establishment of a large data base, 
which may ultimately allow it to be used directly to predict the 
teratogenic risk of a compound or mixture to a variety of organisms, 
including humans. 
To gain acceptance, FETAX must be properly devised so that both 
intra- and interlaboratory variation is minimal. It has been common in 
aquatic toxicity bioassays for the water used as a diluent to vary 
greatly between labs, thereby making results difficult to interpret. 8 
Due to this variation, the use of dechlorinated tap water in FETAX 
would be acceptable only for continuous-flow experiments. 8 ' 9 
Therefore, we set out to dev~lop a reconstituted water formula that 
11 
would allow for proper Xenopus embryo development and at the same 
time reduce the variation associated with an undefined medium. 
This report describes the development of a reconstituted water 
formula for use in FETAX, which we have named FETAX solution. This 
medium allows for excellent development of Xenopus embryos and 
consistently resulted in lower percentages of malformation and 
mortality and increased rates of development and growth of control 
embryos over those we had tested in dechlorinated tap water or modified 
Amphibian Ringers. FETAX solution was then used as the diluent water 
for tests on four compounds previously tested in the other media. The 
results of these comparison tests on a non-teratogen (saccharin), two 
weak teratogens (ethanol and caffeine), and a strong teratogen 
10 (5-fluorouracil), are presented here as well. The results not only 
support the use of FETAX solution but serve as a preliminary report on 
the validation procedure outlined by Smith et a1. 10 for in vitro 
teratogenesis assay validation. 
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Materials and Methods 
The Xenopus adults were obtained from Xenopus I (Ann Arbor, 
MI) and maintained in glass aquaria and/or fiberglass raceways in 
dechlorinated tap water. This water was filtered through activated 
carbon and aerated for 48 h prior to use. It was periodically tested 
to ensure that the pH, dissolved oxygen content, hardness, and content 
of heavy metals and total organic carbon were at acceptable levels. 6 
Adult frogs were fed beef liver and lung supplemented with liquid 
vitamins (Polyvisol). 
Several reconstituted water formulae were tested to determine if 
normal Xenopus embryo growth and development took place. From 
initial tests one formula (FETAX solution) was selected for further 
testing and for comparison with results from tests using dechlorinated 
tap water or modified Amphibian Ringers. FETAX solution is composed of 
625 mg NaCl, 96 mg NaHC0 3 , 30 mg KCl, 15 mg CaC1 2 , 60 mg 
Caso 4 "2H 2 o, and 75 mg Mgso 4 per 1 of deionized, distilled 
water. The pH was 7.9 after mixing and gentle aeration. No additional 
buffer was required to maintain the pH at 7.6 to 7.9. Modified 
Amphibian Ringers contained 1300 mg of NaCl and 30 mg each of KCl, 
CaC1 2 , and Mgso4 per 1 of deionized, distilled water. One-half ml 
of 300 mM Hepes was required to maintain a pH of 7.2 to 7.4 after 
adjustment. 
Breeding tanks and all glassware were washed in dilute HCl, rinsed, 
washed in dilute NaOH, and then rinsed thoroughly in deionized water. 
The tanks were filled with the water medium to be used in the test and 
aerated for a short time before introducing the animals. 
To induce mating, the male and female received 500 and 1000 IU, 
respectively, of human chorionic gonadotropin (Sigma, St. Louis, MO.) 
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via injection into the dorsal lymph sac. Amplexus normally ensued 
within 2 to 6 h and the deposition of eggs took place from 9 to 12 h 
after injection. 
Following breeding the adults and fecal material were removed from 
the tank and the embryos collected in 60 mm plastic Petri dishes. The 
jelly coating surrounding the embryos was removed by gentle swirling 
for 3 to 4 m in a 2% w/v cysteine solution, prepared in the appropriate 
medium. The pH of the cysteine solution was adjusted to 8.1 with NaOH. 
Following the removal of t:he j,=1J,~at, abnormally cleaving 
embryos and necrotic eggs were removed from the collection of embryos. 
A second selection ensured that only normally developing embryos (at 
blastula) were used in the tests. For each test concentration two sets 
of 20 embryos each were placed in plastic Petri dishes containing a 
total of 8 ml of solution. At least four sets of 20 embryos were used 
as controls for each test. The control solutions contained 8 ml of the 
specific medium. The dishes were covered to minimize evaporation. 
Four compounds were tested in FETAX solution for comparison with 
results obtained in the other media. These compounds: saccharin, 
ethanol, caffeine, and 5-fluorouracil, were tested at least twice each 
in dechlorinated tap water and at least once in modified Amphibian 
Ringers, except saccharin which was not tested in the latter. 
All test compounds used in this study were obtained from Sigma. 
The embryos were maintained in the test dishes at 23-24C for 96 h. 
At 24, 48, and 72 h the solutions were changed. Appropriate dilutions 
were made from freshly prepared stock solutions. At the time of daily 
test solution changes, dead embryos were removed and the number dead 
recorded. Determination of gross structural malformations and 
mortality were made using a dissecting microscope. All embryos were 
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scored by the same individual. 11 Death at 24 (stages 26,27) and 48 
h (stages 37-39) was determined by skin pigmentation, structural 
integrity, and irritability of the embryos, while at 72 (stage 42) and 
96 h (stage 46) the absence of a heartbeat in the transparent embryos 
was also used as an indicator of death. In addition the number of 
surviving malformed embryos was determined for each dish and the stage 
of development of the embryos at each concentration noted. 
Structural anomalies typically scored as malformations included 
head and eye irregularities, lack of or improper gut coiling, skeletal 
and heart defects, pericardia!, fin, and head edema, and blistering. 
At 96 h, dead embryos were removed from the dishes and the 
surviving embryos were fixed in formalin (0.5 to 0.75% w/v). The 
numbers of dead and malformed embryos were then noted and recorded. 
Malformed embryos that died prior to 96 h were not included in the 
number malformed. Embryos surviving to fixation were then individually 
measured (head-tail length) using a Radio Shack digitizer and model 
16 microcomputer. 
Dose-response bioassays, evaluated according to 
Litchfield-Wilcoxon, 12 were used to determine the EC50 (malformation) 
and LC50 values for the test compounds. The 96 h EC50 (malformation) 
is the concentration at which 50% of the embryos were malformed at 96 
h. Similarly, the 96 h LC50 is the concentration that produces 50%· 
lethality in the test at 96 h. Division of the 96 h LC50 by the 96 h 
EC50 (malformation) for a test resulted in a Teratogenicity Index (TI) 
value that was useful in estimating the teratogenic risk associated 
with a compound. 5 A compound with a TI of (1.3 was tentatively 
called a non-teratogen. Compounds with TI values of 1.3 to 2.0, 2.0 to 
3.0, and )3.0 were designated as weak, moderate, and strong teratogens, 
15 
respectively. The final determination of the teratogenicity of a 
compound included the types and severity of malformations and the 
percent embryo mortality at the lowest concentration where 100% of the 
surviving embryos were malformed. The t-test for grouped 
observations12 was used to analyze for a significant reduction in 
growth, at p(O.OS, in order to obtain the minimum concentration to 
inhibit growth (MCIG) for each test. 
16 
Results 
The results of initial tests on several reconstituted formulae 
indicated that further testing of one formula (now called FETAX 
solution) was desirable. For brevity only data for FETAX solution is 
presented here, with comparison to control and experimental results 
from tests with the previously used media. After preparation and 
gentle aeration FETAX solution had the following water quality 
parameters. The dissolved oxygen content was 7.0 to 7.2 mg/1, the 
specific conductivity varied from 1600 to 1620 S, and the hardness 
was 112 to 120, expressed as mg/1 of Caco3 • 
Table I compares results for control embryos used in FETAX 
experiments over a two-year period. Statistical analysis using the 
t-test for grouped observations showed a significant (p(O.OS) increase 
in mean length of control embryos in FETAX solution over those in the 
other media. Untreated embryos in FETAX solution typically developed 
to stage 46 at 96 h (the time of fixation) while these embryos in the 
other media normally developed only to stage 45 at 96 h. Although the 
results were not statistically significanti the average control 
mortality and malformation percentages were lower in FETAX solution. 
Table II shows the results for the media tests on saccharin. In 
all tests the TI was approximately 1.0. The 96 h ECSO (malformation) 
and LCSO in both media were from 18 to 21 mg/ml concentration. Figure 
1A represents the dose-response curve for saccharin in FETAX solution. 
The malformations included slight to moderate edema in the pericardial 
region and the dorsal fin, slight tail kinking, and loose or improper 
gut coiling. These malformations were the same in both media and were 
minor in severity. The lowest concentration at which 100% of the 
survivors were malformed always occurred where at least 70% of the test 
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embryos were dead. The minimum concentration to inhibit growth 
(MCIG) of the embryos varied from 12.0 to 17.0 mg/ml. At 20.0 mg/ml 
growth was inhibited by 9 to 15% in dechlorinated tap water and by 13% 
in FETAX solution, when compared to mean control lengths (Figure 2A). 
Results from tests on ethanol in all three media are shown in Table 
II. The TI values for all tests were between 1.3 and 1.9. The 96 h 
ECSO (malformation) range was from 1.0 to 1.2% ethanol (v/v). The 
range for the 96 h LCSO was 1.4 to 2.0%. The dose-response curve for 
ethanol, in FETAX solution, appears in Figure lB. The malformations 
were edema, tail kinking, and loose and improper gut coiling. These 
malformations were slight to moderate at the 96 h ECSO (malformation) 
concentrations and more severe above the 96 h LCSO values. All embryos 
were malformed at concentrations where more than 50% of the embryos 
were dead. The MCIG range was from 0.6 to 1.0% ethanol. At 1.4% 
concentration the growth of embryos was inhibited by 10 and 13% in 
dechlorinated tap water, by 10 and 15% in modified Amphibian Ringers, 
and by 15% in FETAX solution (Figure 2B). 
Caffeine was also tested in all three media and the results are 
shown in Table II. Teratogenicity Index values varied from 1.8 to 2.4 
in the tests. The EC50 (malformation) and LC50 values at 96 h ranged 
from 0.11-0.15 and 0.25-0.30 mg/ml, respectively. The dose-response 
curve for caffeine is shown in Figure 1C. The malformations included 
edema in the head, pericardia!, and fin regions, blistering, tail 
kinking, and improper gut coiling. These malformations were severe at 
all concentrations above 0.175 mg/ml. On all occasions malformations 
in 100% of the survivors first occurred at 0.20 to 0.22 mg/ml caffeine. 
These concentrations were always below the 96 h LC50 value for that 
test. The MCIG ranged from 0.04 to 0.10 mg/ml. At 0.2 mg/ml the 
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growth inhibition when compared to controls was 13 and 22% in 
dechlorinated tap water, 22% in modified Amphibian Ringers, and 13% in 
FETAX solution (Figure 2C). 
Tests on 5-fluorouracil resulted in TI values from about 10 to 12 
(Table II). The 96 h ECSO (malformation) and LCSO concentrations were 
from 0.12-0.14 and 1.22-1.62 mg/ml, respectively. Figure 1D shows the 
dose-response curve for this compound. Severe kinking, absence of or 
improper gut coiling, and severe head and eye abnormalities 
(micropthalmia, microencephaly, and anencephaly) were the typical 
malformations noted. The malformations were severe at concentrations 
near the 96 h ECSO (malformation) values. All surviving embryos were 
malformed at 0.2 mg/ml. This was much lower than the 96 h LCSO values. 
The MCIG was approximately 0.1 mg/ml. The results of the first test 
in dechlorinated tap water are included in Table 2 for comparative 
purposes. In this test the lowest concentration tested was 0.2 mg/ml, 
all these embryos were malformed. At 0.2 mg/ml growth was inhibited by 
10 and 17% in dechlorinated tap water, by 21% in modified Amphibian 
Ringers, and by 10% in FETAX solution. At 0.7 mg/ml growth inhibition 
was always greater than 40% (Figure 2D). 
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Discussion 
Although the percentages of control malformation and mortality in 
FETAX solution were lower than in the other media, the_ difference was 
not statistically significant. It is apparent, however, that FETAX 
solution is superior to the other media for other reasons. Advantages 
of FETAX solution over dechlorinated tap water include the significant 
increase in growth of the controls, the more rapid rate of development, 
and that it is a defined medium. Dechlorinated tap water may contain 
substances that could interact with the test compound, positively or 
negatively. However, we have seen no evidence of this in the present 
test scheme. 
The advantages of FETAX solution over modified Amphibian Ringers 
are the better growth and development rates in the controls, that no 
additional buffer is needed, and the lower percentage of edema in 
controls. This edema accounted for the higher malformation percentage 
and standard error of the mean in controls tested in the modified 
Ringers solution (Table I). This was the main reason we did not like 
this solution as a defined medium for the assay. The growth inhibition 
plots (Figure 2) show that there was some slightvariation in growth in 
the different media. The mean head-tail length was slightly smaller in 
the modified Ringers but no consistent pattern was detected between 
dechlorinated tap water and FETAX solution. 
In this study the criteria used for determining the teratogenicity 
of a compound incorporated information on the severity and extent of 
the malformations, the Teratogenicity Index (TI), and the percent 
embryo mortality at the lowest concentrations where all surviving 
embryos were malformed. The TI was proposed by Dumont et a1. 5 as a 
potential measure of teratogenic risk assessment. The use of a ratio 
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such as this in in vitro teratogenesis test systems has been 
discussed. 10 The TI is similar to the therapuetic index in 
pharmacology that is used as a relative measure of the margin of safety 
for the use of a drug in comparison to other drugs. 13 The 
Teratogenicity Index is not as useful as other ratios which employ both 
adult and developmental testing endpoints. 10 , 14 
The TI values for the compounds tested represent the degree of 
separation between the malformation and mortality curves (Figure lA-D). 
This is directly useful for determining the teratogenic risk of a 
compound. For example, there was a large separation of the 
malformation and mortality curves for 5-fluorouracil (Figure lD) 
indicatingteratogenic effects were observed at far lower concentrations 
than embryo lethality. At the lowest concentrations where most or all 
of the surviving embryos were malformed there was little if any 
mortality. The risk of being alive and malformed at these 
concentrations was very high. By comparison, the malformation and 
mortality curves for saccharin (Figure lA) covered the same 
concentrations and crossed-over. This indicated the chance of being 
alive and malformed was equal to or less than the chance of being dead. 
The degree of teratogenic risk indicated by the TI can not be used 
alone to determine if a compound is a teratogen or not. Courchesne and 
Bantle 6 tested actinomycin D on Xenopus embryos and observed a 
cross-over of the malformation and mortality curves similar to that 
noted for saccharin in this study. A calculated TI for actinomycin D 
would have been (1, indicating a lower risk teratogen. However, the 
malformations induced in embryos exposed to this compound were so 
severe that it was considered teratogenic. 6 Complete testing of the 
compounds suggested by Smith et a1. 10 should establish the validity 
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of the criteria used in FETAX for determining the teratogenicity of a 
compound. Additional methods of analyzing the data to determine 
compound teratogenicity are being evaluated to improve on the present 
scheme. 
All tests of a compound produced similar types and severity of 
malformations and similar TI values .in each medium. For saccharin the 
TI always fell in the range of values (1.3, that for non-teratogens. 
The malformations were minor in nature and 100% of the tadpoles were 
malformed only at concentrations where 70% or more of the test embryos 
were dead. The cross-over of the malformation and mortality curves for 
this compound, shown in Figure 1A, indicated it was toxic in this 
range. In addition the concentration required to produce harmful 
effects was very high (15 mg/ml). Our conclusion was that saccharin 
was not a teratogen to the embryos under our conditions of testing. 
10 This concurs with its designation by Smith et al. who suggested 
inclusion of saccharin as a negative teratogen for in vitro 
teratogenesis assay validation. 
The tests on ethanol produced TI values in the range from 1.3 to 
2.0, the range for a weak teratogen. The dose-response curve for 
ethanol (Figure 1B) showed a slight separation of the malformation and 
mortality curves. This was used as an indication the compound had some 
teratogenic risk. The increased severity of malformations at higher 
concentrations and the occurence of malformations in 100% of the 
embryos just above the 96 h LCSO value, in all tests, added support to 
the TI designation that ethanol was a weak teratogen. Ethanol was 
listed as a weak teratogen by Smith et a1. 10 
We have concluded that caffeine has moderate teratogenicity in 
Xenopus. The TI fell, variously, in the ranges from 1.3-2.0 and 
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2.0-3.0. In three of the four tests the TI was in the latter range, 
indicating that caffeine was a moderate teratogen. There was clearly a 
larger separation of the malformation and mortality curves for caffeine 
(Figure 1C) (along their entire lengths) than for ethanol (Figure 1B). 
Using the additional information on the severity of the malformations, 
especially kinking and blistering, at concentrations just above the 96 
h ECSO (malformation) but below the 96 h LCSO concentrations and the 
occurrence of malformations in all surviving tadpoles below the 96 h 
LCSO for each replicate, our conclusion that caffeine was a moderate 
teratogen, in Xenopus, is supported. This conclusion does not 
specifically agree with its designation by Smith et a1. 10 as a weak 
teratogen, in mammals. However, both conclusions indicate the 
potential teratogenicity of caffeine. 
The large separation of the malformation and mortality curves 
(Figure 1D), the severity of malformations, the degree of separation 
between the lowest point where all tadpoles were malformed (0.2 mg/ml) 
and the 96 h LCSO values (1.22-1.62 mg/ml) in conjunction with the TI 
values from 10 to 12 (Table 2) indicated that 5-fluorouracil was a 
strong teratogen. This conclusion is in agreement with Smith et 
al.10 
The malformations observed in Xenopus embryos due to exposure to 
the four compounds tested were similar to those seen in mammals. A 
disadvantage ofthe 96 h FETAX test is the inability to detect limb and 
digital defects. However, the skeletal kinking observed in the embryos 
may bear some relationship to skeletal limb defects seen in mammalian 
tests. The term skeletal kinking is used to differentiate from kinking 
due to muscular contraction occasionally observed in Xenopus 
tadpoles. Tests with saccharin in rats showed no malformations above 
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control levels. In this study minor malformations, especially 
edema and gut miscoiling, were observed. These abnormalities were 
probably a result of the toxic effects exerted on the embryos at the 
very high concentrations used. Ethanol produced skeletal, 
cardiovascular, head, and eye defects in mice. 16 Early exposure to 
ethanol in Xenopus embryos resulted in craniofacial abnormalities 
17 typical of those seen in Fetal Alcohol Syndrome, while skeletal 
kinking and edema were the predominant malformations observed in this 
study. The malformations in Xenopus embryos due to caffeine exposure 
were severe skeletal kinking, edema, and gut miscoiling. Similarly, 
prolonged caffeine administration in rats resulted in a high incidence 
of generalized edema in addition to visceral and skeletal 
abnormalities 18 and limb defects have been noted. 19 Exposure of 
Xenopus embryos to 5-fluorouracil resulted in severe kinking, gut 
miscoiling, and reduced size of the head, eye, and brain. The 
malformations observed in mice, due to exposure to this compound, were 
head, tail, and limb defects. 20 Exposure of hamsters to 
5-fluorouracil induced tail, limb, palate, gut, eye, and brain 
lf . F 1 h 1 · · d 21 ma ormat1ons. eta growt was a so 1mpa1re • 
Growth inhibition appeared to be a very sensitive endpoint that may 
be used to aid in determining the degree of teratogenicity of a 
compound. Figure 2 is a comparison plot of the growth inhibition for 
each test compound, in each medium tested. The MCIG for saccharin (in 
FETAX solution) was 17.0 mg/ml or 92.5% of its 96 h LC50. The MCIG for 
ethanol (1.0%), caffeine (0.1 mg/ml), and 5-fluorouracil (0.12 mg/ml) 
(in FETAX solution) were 69.4%, 38.9%, and 7.4% of the respective 96 h 
LC50 values. As the teratogenicity of the compound increased the rate 
' 
of growth inhibition and the total reduction in length increased. 
__ , _ _; 
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Although data from many more compounds is needed, this method of 
growth comparison may prove useful in the final determination of the 
degree of teratogenicity associated with a compound. 
Smith et a1. 10 have suggested using compounds from the National 
Toxicology Program (NTP) repository. Because of limited supplies of 
certain NTP compounds and the limited objectives of this study we used 
test compounds purchased from Sigma. 
The variation seen in results for the 4-5 replicate tests on each 
compound can, for the most part, be attributed to variation; due to the 
water medium used, in the actual stock and expected exposure 
concentrations from test to test (and day to day), and in the genetics 
of offspring from separate breedings (especially for the MCIG). 
Reducing variations such as these for both intra- and interlaboratory 
comparisons is important to the utility of any such test system. We 
have addressed the water medium variation in this study. The next step 
is to test FETAX solution, and the assay itself, for interlaboratory 
reproducibility. 
FETAX has broad applicability as an in vitro teratogenesis 
screening assay. It can be used for testing pure compounds6 •22 and 
1 . 5 • 1 d . i 1 h 1 . comp ex m1xtures to eterm1ne potent a arm, not on y to aquat1c 
organisms but mammals (eventually including humans) as well. For now 
FETAX is immediately useful as a r~pid assay to screen and rank samples 
for further mammalian testing. Following complete validation, FETAX 
should enable standardization of information on the teratogenicity of a 
variety of agents and the mechanisms involved in the process. These 
can be done in a rapid and cost-effective manner. 
~'-'''''"-"....,."'M"<, 
Our conclusion for this study is that FETAX solution appears to be 
an excellent medium for use in teratogenic assays. While results of 
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experiments on the four test compounds can not be interpreted as a 
validation of the assay, it does provide incentive and encouragement 
for continued validation efforts of FETAX. 
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Table I. Comparison of FETAX Test Media on Control Embryo Development and Growth.a 
Medium 
Tap Water f 
Control Embryosb 
(n) 
Amphibian Ringers 
FETAX solution 
1480 
560 
2000 
Mortalityc 
(%) 
3.8+0.7 
4 .6+1.4 
2.3+0.9 
a Grouped observations were compared by t-test. 
d Survivors Malformed 
(%) 
3.3+0.6 
7 .1+2.0 
2.7+0.5 
b 
c 
Total number of control embryos tested in the medium from Jan. 84 to Jan. 86. 
The mean control mortality percentage + standard error of the mean. 
e Mean Length 
(mm) 
8 .84+0 .08 
8.92+0.15 
9 .52+0 .11 g 
d 
e 
f 
g 
The mean percentage of surviving malformed control embryos ± standard error of the mean. 
The average mean lengths of the control embryo replicates + standard error of the mean. 
Dechlorinated. 
Value significantly different from the others at p(0.05. 
Table II. Results of media tests on four in vitro teratogenesis assay validation compounds. 
Compound 
Medium-Test II 
96h EC50a 
(malformation) 
(95% Confidence Limits) 
A. Saccharin (mg/ml) 
Dechlorinated 20.71 
Tap Water - Ill (N.A.) 
Dechlorinated 18.12 
Tap Water - 112 (17.4-18.9) 
Dechlorinated 18.05 
Tap \/a ter - 113 (17.8-18.3) 
FE TAX 19.34 
Solution - Ill (18.7-20.0) 
B. Ethanol (% concentration) 
Dechlorinated 
Tap Water - Ill 
1.09 
( 1.00-1.16) 
96h LC50a Tib MCIGc 
(95% Confidence Limits) 
21.09 1.02 12.0 
(18.9-23.5) 
18.32 1.01 N.A. 
(17 .8-18 .8) 
17.94 0.99 17.0 
(17.6-18.3) 
18.37 0.95 17.0 
(18.0-18.8) 
1.45 1.33 1.0 
( 1. 20-1. 7 0) 
Table II cont. 
Dechlorinated 1.20 1.75 1.46 0.6 
Tap Water - 112 (1.06-1.36) (1.51-2.02) 
Amphibian 1.06 1.99 1.88 0.6 
Ringers - Ill (0.94-1.19) (1.91-2.09) 
Amphibian 1.04 1.78 1.71 0.6 
Ringers - 112 (0.98-1.10) (1.74-1.81) 
FE TAX 1.01 1.44 1.43 1.0 
Solution - Ill (0.95-1.09) (1.20-1. 71) 
c. Caffeine (mg/ml) 
Dechlorinated 0.146 0.297 2.03 0.075 
Tap Water - Ill (0.07-0.30) (0.26-0.32) 
Dechlorinated 0.152 0.276 1.83 0.040 
Tap Water - /12 (0.14-0.16) (0.25-0.30) 
Amphibian 0.107 0.252 2.36 0.080 
Ringers - Ill (0.10-0.12) (0.22-0.29) 
FE TAX 0.128 0.257 2.01 0.100 
Solution - Ill (0.12-0.14) (0.21-0.31) 
Table II cont. 
--
D. 5-fluorouracil (mg/ml) 
Dechlorinated N.A. 1.47 N.A. N.A. 
Tap Water - Ill (1.29-1.66) 
Dechlorinated 0.120 1.22 10.17 0.0875 
Tap Water - 112 (O.ll-0.13) (1.07-1.39) 
Amphibian 0.124 1.26 10.16 0.090 
Ringers - Ill (0.12-0.13) (1.17-1.36) 
FE TAX 0.137 1.62 11.82 0.120 
Solution - Ill (0.12-0.16) ( 1.56-1.68) 
a Statistical analysis using the Litchfield-Wilcoxon dose-response test. 
b Teratogenicity Index= 96h LC50/96h EC50 (malformation). 
c MCIG - Minimum Concentration to Inhibit Growth; analyzed by the t-test for grouped 
observations (p(0.05). 
N.A. not available. 
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Figure Legends 
Figure 1. Dose-response curves for Xenopus embryo malformation ( Q) 
and mortality (D) after 96 hours of exposure to A. saccharin (mg/ml), 
B. ethanol (%concentration), c. caffeine (mg/ml), and D. 
5-fluorouracil (mg/ml), in FETAX solution. 
Figure 2. Representative growth curves for Xenopus embryos after 96 
hours of exposure to: A. saccharin, B. ethanol, C. caffeine, D. 
5-fluorouracil; prepared in dechlorinated tap water (()),modified 
Amphibian Ringers ( • ) , or FETAX solution ( D). 
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CHAPTER III 
COADMINISTRATION OF METHYLXANTHINES AND INHIBITOR 
COHPOUNDS POTENTIATES TERATOGENICITY 
IN XENOPUS EMBRYOS 
Abstract 
Inhibitors of DNA synthesis (hydroxyurea and cytosine arabinoside), 
protein synthesis (cycloheximide and emetine), and nucleic acid 
synthesis (5-fluorouracil) were administered with each of three 
methylxanthines (caffeine, theophylline, and theobromine) to determine 
if teratogenic effects could be potentiated in Xenopus laevis 
embryos. The animals were exposed for 96 hours to methylxanthine and 
inhibitor concentrations that alone, produced low percentages of 
malformations. 
Coadministration of caffeine or theophylline with each inhibitor 
greatly increased the incidence of malformed embryos. Similar 
potentiation was induced when theobromine and the protein synthesis 
inhibitors were tested. A lesser potentiative response was produced 
when theobromine and the nucleic acid synthesis inhibitor were 
administered together. Teratogenic potentiation did not occur when 
theobromine was administered in conjunction with the DNA synthesis 
inhibitors. Growth reduction in the treatments proved to be the most 
sensitive indicator of the potentiative effects. 
This study had two significant findings: the teratogenicity of the 
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protein synthesis inhibitors was greatly increased upon 
coadministration with each methylxanthine, even though they are 
typically not very teratogenic by themselves, and coadministration of 
the DNA synthesis inhibitors with theobromine did not result in 
teratogenic potentiation. Additionally, this study serves as one 
method of validating the Frog Embryo Teratogenesis Assay-Xenopus 
(FETAX), since the results obtained concur with results from similar 
mammalian studies. 
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Introduction 
Amphibian embryos have been employed by a number of investigators 
to evaluate the teratogenic and toxic potential of a variety of 
chemicals and agents (Dial, '76; Greenhouse, '76; Birge et al., '85). 
A frog embryo teratology screen ("FE TAX") has been developed (Dumont et 
al., '83) and tested in several laboratories (Courchesne and Bantle, 
'85; Dawson et al., '85; Sabourin et al., '85). As a part of the 
validation procedure for this assay, we investigated the phenomenon of 
teratogenic potentiation between two ag~nts in Xenopus embryos. 
Three methylxanthines (caffeine, theophylline, and theobromine) were 
selected and their interactions with inhibitors of DNA (hydroxyurea, 
cytosine arabinoside), protein (cycloheximide, emetine), and nucleic 
acid synthesis (5-fluorouracil) studied. Earlier studies in in 
vivo mammalian systems (Ritter et al., '82; Nakatsuka et al., '83) 
had indicated potentiation with two of these xanthines (caffeine and 
theophylline but not theobromine). 
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Materials and Methods 
The Xenopus adults were obtained from Xenopus I (Ann Arbor, 
MI) and maintained in glass aquaria and/or fiberglass raceways in 
dechlorinated tap water. This water was filtered through activated 
carbon and aerated for 48 hours prior to use. The water was 
periodically tested to ensure that the pH, dissolved oxygen content, 
hardness, and content of heavy metals and total organic carbon were at 
acceptable levels (Courchesne and Bantle, '85). Adult frogs were fed 
beef liver and lung supplemented with baby vitamins (Polyvisol). 
Breeding tanks (and all glassware used in this study) were washed 
in dilute HCl, rinsed, washed in dilute NaOH, and then rinsed 
thoroughly in deionized water. The tanks were filled with FETAX 
Solution (Dawson and Bantle, 1987) and aerated for a short time before 
introducing the animals. FETAX Solution is composed of 625 mg NaCl, 96 
mg NaHco 3 , 30 mg KCl, 15 mg cac1 2 , 60 mg Caso 4 "2H 2o, and 75 
mg Mgso4 per liter of deionized distilled water. 
To induce mating, the male and female received 500 and 1000 IU, 
respectively, of human chorionic gonadotropin (Sigma, St. Louis, MO.) 
via injection into the dorsal lymph sac. Amplexus normally ensued 
within two to six hours and the deposition of eggs took place from nine 
to twelve hours after injection. 
Following breeding the adults and fecal material were removed from 
the tank and the embryos collected in 60 mm plastic Petri dishes. The 
jelly coating surrounding the embryos was removed by gentle swirling 
for three to four minutes in a 2% w/v cysteine solution, prepared in 
FETAX Solution. The pH of the cysteine solution was adjusted to 8.1 
with NaOH. After removal of the jelly coat, abnormally cleaving 
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embryos and necrotic eggs were removed from the collection of 
embryos. A second selection ensured that only normally developing 
embryos (at blastula) were used in the tests. 
Preliminary tests were conducted to determine the best 
concentration of caffeine and each inhibitor to use in the experiments. 
The concentrations of theophylline and theobromine used were equimolar 
to caffeine. For each separate clutch of embryos four sets of 20 
embryos each were placed in plastic Petri dishes containing 8 ml of 
FETAX Solution, as controls. Controls for each methylxanthine and 
inhibitor compound were set up in a similar manner, as were the 
methylxanthine and inhibitor mixtures. All dishes contained a total of 
8 ml of the appropriate solution(s), which had been diluted from stocks 
prepared in FETAX Solution. The dishes were covered to minimize 
evaporation. Two separate experiments were performed on each inhibitor 
compound. 
All test compounds used in this study were obtained from Sigma. 
The embryos were maintained in the test dishes at 23-24°C for 96 
hours. At 24, 48, and 72 hours the solutions were changed. 
Appropriate dilutions were made from freshly prepared stock solutions. 
At the time of daily solution changes dead embryos were removed and the 
number dead recorded. Death at 24 (stages 26,27) (Nieuwkoop and Faber, 
'75) and 48 hours (stages 37-39) was determined by skin pigmentation, 
structural integrity, and irritability of the embryos, while at 72 
(stage 42) and 96 hours (stage 46) the absence of a heartbeat (visible) 
was also used as an indicator of death. In addition the number of 
surviving malformed embryos was determined for each dish and the stage 
of development of the embryos noted. Structural anomalies typically 
scored as malformations included head and eye irregularities, absence 
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of or improper gut coiling, skeletal and heart defects, pericardial, 
fin, and head edema, and blistering. 
At 96 hours, dead embryos were removed from the dishes and the 
surviving embryos were fixed in formalin (0.5 to 0.75%). The numbers 
of dead and malformed embryos were then determined. Malformed embryos 
that died prior to fixation were not included in the number malformed. 
Embryos surviving to fixation were then individually measured 
(head-tail length) using a Radio Shack digitizer and model 16 
microcomputer. 
Analysis of variance and the Student-Newman-Keuls range test were 
used to analyze for statistical significance at p<0.05 and p<0.001 
(Steel and Torrie, '80). The analysis was conducted by comparing mean 
malformation and mortality percentages and mean growth lengths between 
treatments, for the tests with each inhibitor. 
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Results 
Eighty embryos were treated as experimental controls for each 
clutch of embryos. Similar methylxanthine control treatments were 
established for each breeding. Mortality and malformation percentages 
for the experimental and methylxanthine controls may overlap to some 
degree between inhibitor compounds, depending on the number of 
inhibitors tested on each clutch. Specific experimental and 
methylxanthine control results for the tests with each inhibitor are 
presented in Tables III-VII. In the study a total of 560 embryos were 
treated as controls. Five of these died (0.9%) and 13 of the survivors 
were malformed (2.3%). The malformations were limited to pericardia! 
and dorsal fin edema with the exception that two also had skeletal 
kinking. Caffeine at 0.08 mg/ml exposure concentration and 
theophylline and theobromine at 0.075 mg/ml (equimolar to caffeine) 
were used as the methylxanthines in all of the experiments. Each 
methylxanthine alone was tested on a total of 560 embryos as well. The 
mortality percentages for the methylxanthine control treatments, in the 
order presented above, were 1.6%, 2.3%, and 3.6%. The malformation 
percentages for the surviving embryos were 8.0%, 7.3%, and 4.1%, 
respectively. Throughout the study the malformations observed in each 
of the methylxanthine control treatments were limited to edema in the 
pericardium and dorsal fin and, occasionally, slight skeletal kinking. 
The results of the coadministration of each methylxanthine and 
hydroxyurea on Xenopus embryo development, survival, and growth after 
96 hours of exposure are presented in Table III. The average replicate 
malformation percentage in the embryos treated with 0.3 mg/ml of 
hydroxyurea, a DNA synthesis inhibitor, was 20.6%. None of the embryos 
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in this treatment died. The malformations observed were slight to 
moderate skeletal kinking and occasional fin edema and improper gut 
coiling. When caffeine or theophylline was coadministered with 
hydroxyurea, at the appropriate concentrations, a significant increase 
in both mortality (p(0.05) and malformation (p(O.OOl) percentages was 
observed over that seen for the hydroxyurea treatment alone. Caffeine 
and hydroxyurea together produced 6.9% death in the embryos and 89.0% 
of the survivors were malformed. Theophylline in combination with 
hydroxyurea resulted in death in 8.1% of the embryos while 50.6% of the 
survivors were malformed. No additional types of malformations were 
noted, but the severity of the edema and kinking was judged to be 
greater, overall. Theobromine coadministered with hydroxyurea resulted 
in death in 3.1% of th~ embryos and 25.2% of the survivors were 
malformed. There was no statistical difference in these percentages 
from those obtained for hydroxyurea alone. No enhancement of the 
skeletal kinking was observed when theobromine was coadministered with 
hydroxyurea but the degree of edema was variable. Throughout the 
study, the mean head-tail length (growth) of the embryos appeared to be 
the most sensitive indicator of treatment effects. 
The results of tests on the interaction of the DNA synthesis 
inhibitor cytosine arabinoside with each methylxanthine are shown in 
Table IV. There was no significant difference in mortality in any of 
the treatments. Cytosine arabinoside alone, at 0.6 mg/ml, produced 
malformations in 23.6% of the survivors. The malformations were 
limited to edema and skeletal kinking, ventrally, at the tip of the 
tail. As with hydroxyurea, coadministration of caffeine or 
theophylline with this inhibitor produced a statistically significant 
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(p<O.OOl) increase in the average replicate malformation percentage. 
In this case the malformation percentages for these two 
coadministration treatments were approximately the same, with 77.6% of 
the surviving embryos in the caffeine and cytosine arabinoside 
treatment malformed and 76.0% of the survivors in the theophylline and 
inhibitor treatment malformed. In both of these treatments the typical 
malformations observed were edema and a bowing of the tail with the 
ventral tail flexure at the tip. The embryos were judged to be more 
severely malformed due to the additional bowing in the tail. A second 
theobromine concentration was included in the tests with this 
inhibitor, in order to determine whether a higher concentration of 
theobromine would result in potentiation of the teratogenic effects. 
This concentration (0.12 mg/ml) produced 5.6% death and 11.1% of the 
surviving embryos were malformed. These values were slightly higher 
than occurred in the lower theobromine concentration (Table IV) but 
they were not statistically different. At both concentrations of 
theobromine in combination with cytosine arabinoside the percentages of 
the malformations (30.4% and 34.1% respectively) were approximately the 
sum of the malformation percentages for the respective theobromine and 
cytosine arabinoside treatments alone. These percentages were not 
statistically different from the malformation percentage for cytosine 
arabinoside alone at p<O.OOl. However, t.he malformation percentage for 
the higher theobromine concentration with the inhibitor was 
statistically different from that for cytosine arabinoside alone at 
p<O.OS. The malformations observed in the coadministration treatments 
of theobromine and cytosine arabinoside were typical of those seen in 
cytosine arabinoside alone. 
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The results of the interaction of the nucleic acid synthesis 
inhibitor 5-fluorouracil (5-FU) and each methylxanthine are shown in 
Table v. The mortality percentages for the treatments were not 
statistically different. The percentage of malformed survivors in 5-FU 
alone, at 0.08 mg/ml, was 24.1%. Skeletal kinking and improper gut 
coiling were typically observed, while pericardia! and fin edema were 
occasionally noted. Coadministration of caffeine or theophylline with 
5-FU produced malformations in 85.7% and 87.8% of the survivors, 
respectively. In addition to more severe skeletal kinking, improper 
eye development was noted. Theobromine in combination with 5-FU also 
produced a statistically significant (p<O.OOl) increase in the 
percentage of malformed survivors (42.5%) compared to that obtained for 
5-FU alone. The skeletal kinking was judged to be only slightly more 
severe and only a few of the malformed embryos had the eye defect. 
Cycloheximide, a protein synthesis inhibitor, was also tested with 
each methylxanthine and these results are presented in Table VI. There 
was a statistical difference in mortality percentage between some of 
the treatments. Cycloheximide at a concentration of 0.04 ug/ml, 
resulted in malformations in 18.4% of the survivors. Slight kinking, 
edema, and necrosis of a portion of the dorsal fin were noted in these 
embryos. Coadministration of each methylxanthine with this inhibitor 
resulted in a statistically significant increase (p<O.OOl) in the 
average replicate malformation percentage. The malformation 
percentages were 80.7%, 69.6%, and 70.6% for cycloheximide administered 
with caffeine, theophylline, or theobromine, respectively. The kinking 
and edema were only slightly more severe but blistering in the dorsal 
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fin was observed in the area where the necrosis was noted in 
malformed embryos in cycloheximide alone. 
A second protein synthesis inhibitor, emetine, was also 
coadministered with the methylxanthines. The results are shown in 
Table VII. Emetine alone, at 0.7 ug/ml, produced malformations in 
28.9% of the survivors. The malformations included slight lateral 
kinking of the tail, predominantly to the left, and occasional 
blistering along the edge of the eyes. When emetine was coadministered 
with caffeine, theophylline, or theobromine the percentage of malformed 
survivors, 81.4%, 87.5%, and 81.7% respectively, was increased 
significantly (p<O.OOl). In all three cases the tail kinking was of 
the same relative order of severity and was similar to that observed in 
emetine alone. Nearly all of the malformed survivors in the 
coadministration treatments had the blistering around the eyes, of 
varying severity. As with cycloheximide, the malformation percentages 
between the coadministration treatments were the same statistically. 
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Discussion 
The results of this study showed that coadministration of 
caffeine or theophylline with each of the inhibitor compounds resulted 
in potentiation of the teratogenic effect. Coadministration of 
theobromine and the protein synthesis inhibitors (cycloheximide, 
emetine) or 5-fluorouracil (5-FU) also resulted in teratogenic 
potentiation. In contrast only an additive effect was observed between 
theobromine and the inhibitors of DNA synthesis (hydroxyurea, cytosine 
arabinoside). We failed to note potentiation of cytosine arabinoside 
teratogenicity even when the dose of theobromine was raised from 0.075 
to 0.12 mg/ml. A lack of potentiation between theobromine and 
mitomycin C (a DNA synthesis inhibitor) has been reported by Nakatsuka 
et al. ('83) in mice. Mitomycin C teratogenicity was potentiated by 
both caffeine and theophylline (Nakatsuka et al., '83). Ritter et al. 
('82) demonstrated that coadministration of caffeine with hydroxyurea, 
cycloheximide, and emetine resulted in potentiation of embryo toxicity 
in rats. 
In all treatments where potentiation took place the types of 
malformations in the combined treatments were typical of those noted 
with the inhibitors alone. The increased number of eye malformations 
observed when a methylxanthine was administered with emetine or 5-FU 
indicated that the teratogenicity of the inhibitors was potentiated by 
the action of the methylxanthines since none of the methylxanthines 
alone typically produced eye malformations. Dose-response tests on 
emetine and 5-FU alone have demonstrated a high incidence of eye 
malformations (unpublished observations). 
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The results of statistical comparisons of growth data from the 
tests produced the most sensitive indicator of the treatment effects 
(Tables III-VII). In general, growth was inhibited most in the 
treatments where teratogenic potentiation occurred. Emetine was an 
exception in the tests since embryos exposed to this inhibitor alone 
had a mean head-tail length equal to that of the controls (Table VII). 
Methylxanthine and emetine treatment only slightly reduced head-tail 
length. 
The goal of this study was to determine whether the teratogenic 
effects of DNA, protein, and nucleic acid synthesis inhibitors could be 
potentiated in Xenopus embryos upon coadministration with 
methylxanthines. By demonstrating that such potentiation did occur, as 
it had in mammals, the study helps to validate the use of FETAX as an 
in vitro teratogenesis assay. This study has also demonstrated 
that FETAX could be used to study the structure-activity relationships 
of a family of compounds with respect to teratogenicity and that it has 
utility as a basic research tool for studying teratogenic processes. 
Our emphasis was on validation, therefore we did not attempt 
experiments that would elucidate the molecular nature of these effects. 
Future studies can be performed that may help to determine the 
mechanisms involved in this type of potentiation and to determine why 
theobromine does not potentiate the teratogenicity of DNA synthesis 
inhibitors. 
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Table III. Effects of hydroxyurea and methylxanthines alone and1in combination 
on Xenopus embryo development and growth at 96 hours • 
Treatment 
Controls 
Hydroxyurea (Hyd) 
Caffeine (Caf) 
Caf & Hyd 
Theophylline (Tp) 
Tp & Hyd 
Theobromine (Tb) 
Tb & Hyd 
No. of2 
embryos 
160 
160 
160 
160 
160 
160 
160 
160 
mean length 3 No. dead 
(mm) (%) 
9.46-I-O.lla 0 (O)g 
9.25+0.13 b 0 (O)g 
c 0 (O)g 9 .09+0 .ll d* 
8.30+0.09 ll (6.9)h 
c 0 (O)g 9 .05_±0 .10 e* 
8.64+0.14 13 (8.1)h 
b 4 (2.5)g,h 9.30_±0.09f* 
8.86+0.15 5 (3.1)g,h 
Concentrations: Hyd = 0.3 mg/ml; Caf = 0.08 mg/ml; Tp & Tb 
1Analysis of variance and Student-Newman-Keuls range test. 
No. of survivo4s 
malformed (%) 
-
1 (0.6)i 
33 (20.6)j 
13 (8.1)i 
132 (89.0)k 
i 12 (7.5)1 
74 (50.6) 
i 7 (4.5). 
39 (25.2)] 
0.07 5 mg/ml. 
2Two separate experiments, each with four replicates of twenty embryos. 
3Mean head-tail length of surviving embryos + standard error of the mean. 
4Average of the replicate percentages of surviving malformed embryos. 
a,b,c,d,e,fare significantly different from each other at p(0.05. 
g,hare significantly different from each other at p(0.05. 
i,j,k,lare significantly different from each other at p(0.001. 
* indicates significance from all other treatments at p(0.001. 
Table IV. Effects of cytosine arabinoside and methylxanthines alone and in1 
combination on Xenopus embryo development and growth at 96 hours • 
Treatment No. of2 
embryos 
mean length3 
(mm) 
No. dead 
(%) 
No. of survivo4s 
malformed (%) 
Controls 
Cytosine 
arabinoside (Ara-C) 
Caffeine (Caf) 
Caf & Ara-C 
Theophylline (Tp) 
Tp & Ara-C 
Theobromine (Tb) 
Tb & Ara-C 
160 
160 
160 
160 
160 
160 
160 
160 
Theobromine 0.12 (Tbx) 160 
Tbx & Ara-C 160 
9.36+0.08a 
9.12+0.08b,c 
d 8.93+0.06 
- e 8.47+0.09 
9 0 0 1+0 0 08 c, d 
- e 8.41+0.09 
b 9.21:!:0.07d 
8 .88+0 .14 
9.02+0.08~,d 
8 .69+0 .10 
3 (1.9) 
3 (1.9) 
3 (1.9) 
4 (2.5) 
3 (1.9) 
5 (3.1) 
7 (4.4) 
6 (3.8) 
9 (5.6) 
2 (1.3) 
Concentrations: Ara-C = 0.6 mg/ml; Caf = 0.08 mg/ml; Tp & Tb 
1Analysis of variance and Student-Newman-Keuls range test. 
5 (3.1)g 
37 (23.6)h 
12 (7.7)~ 
121 (77.6) 1 
11 (6.9)~ 
118 (76 .0) 1 
6 (3.8)g 
47 (30.4)h 
17 (11. 1)~* 
56 (34.1) 
= 0.07 5 mg/ml. 
2Two separate experiments, each with four replicates of twenty embryos. 
3Mean head-tail length of surviving embryos + standard error of the mean. 
4Average of the replicate percentages of sur~iving malformed embryos. 
a,b,c,d,e,fare significantly different from each other at p(O.OOl. 
g,h,iare significantly different from each other at p(O.OOl. 
* indicates significance from Ara-C alone treatment at p(O.OS. 
Table V. Effects of 5-fluorouracil and methylxanthines alone fnd in combination 
on Xenopus embryo development and growth at 96 hours . 
No. of2 
3 No. dead Treatment mean length 
embryos (mm) (%) 
Controls 160 9.38+0.06 a* 1 (0.6) 
5-fluorouracil (5-Fu) 160 9.02+0.06 b 3 (1.9) 
-
Caffeine (Caf) 160 8.98.:!:_0.03~~c 3 (1.9) 
Caf & 5-Fu 160 8 .18+0 .10 6 (3.8) 
Theophylline (Tp) 160 e* 7 (4.4) 9 .13+0 .02f* 
Tp & 5-Fu 160 8.63+0.07 3 (1.9) 
-
Theobromine (Tb) 160 g* 5 (3.1) 9.29+0.05 
- c Tb & 5-Fu 160 8.93+0.07 0 (0) 
Concentrations: 5-Fu & Caf = 0.08 mg/ml; Tp & Tb = 0.075 mg/ml. 
1Analysis of variance and Student-Newman-Keuls range test. 
No. of survivo4s 
malformed (%) 
4 (2.5)h 
38 (24.l)i 
12 (7.7)~ 
132 (85.7)] 
h 12 (7.8). 
138 (87 .8)J 
7 (4.4)h 
68 (42.5)k 
2Two separate experiments, each with four replicates of twenty embryos. 
3Mean head-tail length of surviving embryos + standard error of the mean. 
4Average of the replicate percentages of sur~iving malformed embryos. 
a,b,c,d,e,f,gare significantly different from each other at p<O.OS. 
h,i,j,kare significantly different from each other at p(O.OOl. 
* indicates significance from all other treatments at p(O.OOl. 
Table VI. Effects of cycloheximide and methylxanthines alone ard in combination 
on Xenopus embryo development and growth at 96 hours • 
Treatment No. of2 
3 No. dead No. of survivo!s mean length 
embryos (mm) (%) malformed (%) 
Controls 160 9.38+0.06a 1 (0.6)i 4 (2.5l 
Cycloheximide (Cyh) 160 8.77+0.09 b* 3 (1.9)i 29 (18.4) 1 
-
Caffeine (Caf) 160 c* 3 i 12 (7.7l' 1 8.98::!:_0.03d* (1.9). . 
Caf & Cyh 160 8.35+0.05 12 (7.5)1,] 119 ( 80 0 7) m+ 
-
Theophylline (Tp) 160 e* 7 (4.4)i'~ 12 (7 .8)k,l 9.13+0.02f 
Tp & Cyh 160 8.62+0.06 7 (4.4)i,J 106 (69.6)m+ 
-
Theobromine (Tb) 160 9.29±_0.05~ 5 (3.l)~'j 7 (4.4)k 
Tb & Cyh 160 8.54+0.06 16 (10 .o)J 102 (70.6)m+ 
Concentrations: Cyh = 0.04 Mg/ml; Caf = 0.08 mglmll; Tp & Tb = 0.075 mg/ml. 
1Analysis of variance and Student-Newman-Keuls range test. 
2 Two separate experiments, each with four replicates of twenty embryos. 
3Mean head-tail length of surviving embryos + standard error of the mean. 
4Average of the replicate percentages of sur~iving malformed embryos. 
a,b,c,d,e,f,g,hare significantly different from each other at p(0.05. 
i,jare significantly different from each other at p(0.05. 
k,l,mare significantly different from each other at p(0.05. 
* indicates significance from all other treatments at p(O.OOl. 
+indicates significance from all treatments lacking this designation at p(O.OOl. 
Table VII. Effects of emetine and methylxanthines alone and in tombination 
on Xenopus embryo development and growth at 96 hours • 
Treatment 
Controls 
Emetine (Erne) 
Caffeine (Caf) 
Caf & Erne 
Theophylline (Tp) 
Tp & Erne 
Theobromine (Tb) 
Tb & Erne 
No. ofz 
embryos 
160 
160 
160 
160 
160 
160 
160 
160 
mean length 3 
(mm) 
9.93+0.17a 
9.97+0.21a 
9.47+0.20b,c 
- . c 9 .34+0 .17 
9.60+0.19b,d 
- c 9.33+0.21 
9.82+0.18a,e 
9.69+0.18d,e 
No. dead 
(%) 
No. of survivo4s 
malformed (%) 
-
3 (1.9) 6 (3.8/ 
4 (2.5) 45 (28.9)g 
4 (2.5) 
4 (2.5) 
f 16 (10.3)h 
127 (81.4) 
4 (2.5) 
8 (5.0) 
13 (8.3/ 
133 (87.5)h 
8 (5.0) 
12 (7.5) 
8 (5.1/ 
121 (81. 7)h 
Tb = 0.075 mg/ml. Concentrations: Erne = 0.7 pg/ml; Caf = 0.08 mg/ml; Tp & 
1Analysis of variance and Student-Newman-Keuls range test. 
2Two separate experiments, each with four replicates of twenty embryos. 
3 Mean head-tail length of surviving embryos + standard error of the mean. 
4Average of the replicate percentages of surviving malformed embryos. 
a b c d e . 
' ' ' ' are sign1ficantly different from each other at p(0.05. 
f,g,hare significantly different from each other at p(O.OOl. 
CHAPTER IV 
EVALUATION OF THE DEVELOPMENTAL TOXICITY OF 
METAL-CONTAMINATED SEDIMENTS USING 
SHORT-TERM FATHEAD MINNOW AND 
FROG EMBRYO-LARVAL ASSAYS 
Abstract. 
The effects of metal-contaminated sediment extracts and a 
reference toxicant (zinc sulfate) were determined by examining the 
developmental morphology, growth, and mortality of exposed fathead 
minnow (Pimephales promelas) and frog (Xenopus laevis) embryos. 
Sediments from two contaminated stream sites were extracted with 
reconstituted culture water at various pH's for 24 h. Developmental 
toxicity tests were performed using the FETAX protocol. The results 
suggested Zn was the major developmental toxicant in the sediment 
extracts. The measured Zn concentration in the sediment extracts which 
caused 50% malformation (ECSO) of the fish embryos was 0.5 to 1.4 mg/L 
(normalized to 100 mg/L hardness). ECSO values for the reference 
toxicant tests were 0.6 and 0.8 mg/L Zn. The frog embryo ECSO for the 
extracts ranged from 2.2 to.3.6 mg/L Zn and was 3.6 mg/L Zn in the 
reference toxicant test. In 67% of the tests malformation was a more 
sensitive endpoint than growth inhibition. Mortality was the least 
sensitive endpoint, i.e., the LCSO in the reference toxicant tests were 
3.6 mg/L Zn for the fathead minnow and 34.5 mg/L for the frog. The 
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extraction procedure may be useful for determining potential toxicity 
in the event metals are leached from aquatic sediments due to dredging 
or acidification. 
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Introduction 
A major obstacle in evaluating the effects of aqueous 
contaminants has been the gap between the use of short-term lethal 
effects assays and assays that measure long-term chronic responses. 
Attempts to assess long-term effects without doing complete life cycle 
studies have focused on assays that measure effects on especially 
sensitive life processes such as reproduction and development. 
Therefore, examining gross terata during morphological development may 
help determine sublethal effects of contaminants [1]. 
Survival, growth, and reproduction responses of fathead minnows 
have been widely used for assaying contaminant effects [2-4] while 
inclusion of teratogenic effects has been a relatively recent 
development [1,5-6]. Frog embryos have been used for more than a 
decade to detect abnormal development caused by exposure to aqueous 
contaminants [7-9]. FETAX (Frog Embryo Teratogenesis Assay-
Xenopus) was developed to rapidly and inexpensively determine the 
deleterious effects of sublethal levels of contaminants upon animal 
development [9-12]. The assay includes malformation as a distinct 
measure of effect, separate from survival and growth endpoints. 
FETAX was used to detect heavy metal teratogens in water samples 
from Tar Creek, a stream in northeastern Oklahoma that had been 
contaminated by acidified mine-water surface seeps [12]. Heavy metals, 
especially Zn, accumulated in the sediments of Tar Creek and the Neosho 
River as a result of the contamination. McCormick developed a sediment 
extraction procedure with reconstituted water to permit bioassay 
evaluation of the release of harmful levels of metals from these 
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aquatic sediments prior to actual leaching that might occur during 
events such as hydraulic dredging or acidification [13]. 
In this study, metal-contaminated sediments were extracted in 
reconstituted water and the effects of the extracts and a reference 
toxicant (zinc sulfate) on morphological development, growth, and 
survival of fathead minnow and frog embryos were examined in order to 
evaluate the potential toxicity of the contaminated aquatic sediments. 
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Materials and Methods 
Composite sediment samples from two sites, Tar Creek (S5, T28N, 
R23E) and Neosho River (S26, T27N, R23E) in Ottawa County, Oklahoma, 
were prepared for extraction [13] in modified FETAX solution (MFS). 
This reconstituted water medium contained 400 mg NaCl, 96 mg NaHco3 , 
30 mg KCl, 15 mg CaC1 2 , 60 mg Caso 4 ·2H 2o, and 75 mg Mgso4 per 
liter of deionized distilled water. The pH of MFS was 7.9 with an 
average hardness and alkalinity of 106 and 72 mg/L Caco 3 , 
respectively. Preliminary tests indicated both fathead minnow and frog 
embryos could develop normally in this solution. 
Extraction was modified from the method of McCormick [13] with 
extractions performed at pH 4, 5, 6, or 7. For each extraction, 50 g 
of sediment was added to 1 liter of MFS and the pH was then adjusted to 
the d~sired level with acetic acid (pH 4, 5, and 6) or NaOH (pH 7). 
Extractions were performed separately on the sediment sample aliquots 
from each site, using a new aliquot of sediment at each pH. The 
extraction procedure was repeated a second time at pH 4, 5, or 6, using 
new sediment aliquots for each site and pH. Extractions at pH 7 were 
not repeated. The extractions were performed in polypropylene bottles 
for 24 h, using a rotating tumbler. At 1, 6, 16, and 24 h of 
extraction the pH was readjusted, if necessary. During extraction, the 
pH varied by no more than + 0.8, 0.6, 0.3, and 0.2 s.u. from the 
desired extraction pH at 1, 6, 16, and 24 h, respectively. An 
equipment malfunction necessitated stopping the first pH 5 and the pH 7 
extractions after 20 h. The suspended sediment material was allowed to 
settle for 24 h after extraction. The solutions ~;;rere then centrifuged 
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at 1475 x g for 10 min and the supernatants filtered (Whatman #1 
filter paper). All extraction filtrates were readjusted to pH 7 with 
NaOH prior to use in the developmental toxicity tests. Readjustment to 
pH 7 was necessary to avoid toxic effects due to low pH. At each pH, a 
sample of MFS alone was carried through the extraction procedure, to 
serve as a control. An aliquot of each pH readjusted extract and 
control solution was analyzed for nonfilterable metals concentration by 
atomic absorption [14]. 
A portion of one Neosho River sediment extract (pH 4) was passed 
twice over Chelex-100 (Bio-Rad) to remove divalent metal ions, to 
determine if metals were primarily responsible for the effects observed 
[12,15]. An extracted MFS sample was also chelated as a control. 
Animal culture and breeding procedures were as described for 
fathead minnows (Pimephales promelas) [16] and frogs (Xenopus 
laevis) [12]. Normally developing embryos at the gastrula (fathead 
minnow) or blastula (frog) stages were placed in various dilutions of 
the pH readjusted (7.0) extracts. These dilutions were based on the 
measured Zn concentration of each sample. The tests were conducted in 
covered plastic Petri dishes [12]. At each dilution, 10 to 20 fathead 
minnow embryos were tested in each of two dishes containing 10 ml of 
solution while 15 to 20 frog embryos were tested in each of two dishes 
containing 8 ml of solution [12]. Controls were tested in both MFS and 
extracted MFS. 
Static renewal tests were conducted for 6 d with fathead minnow 
embryos (to allow hatching to take place) and 4 d with frog embryos 
[9]. During the tests, pH, conductivity, and dissolved oxygen 
parameters were measured daily on each sample while hardness and 
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alkalinity were determined at the start and end of each test and on 
various other days. All tests were conducted at 22 to 24°C. Dead 
organisms were counted and removed at daily renewal. At the end of 
each test surviving larvae were fixed in formalin. Gross terata (eg. 
head, eye, gut, skeletal, and cardiovascular abnormalities and edema) 
were determined using a dissecting microscope. Malformed individuals 
that died prior to test termination were not included in the number 
malformed [9]. Head-tail length of the organisms was used as an index 
of growth [12]. 
Since previous work had implicated Zn as the suspect deleterious 
contaminant, zinc sulfate (Znso 4 "7H 20) was chosen as the 
reference toxicant to permit comparison of the observed effects of the 
sediment extracts with a known toxicant. Initial tests using frog 
embryos determined the response ranges to zinc sulfate. Full reference 
toxicant tests were conducted twice for the fish embryos and once for 
the frogs. As with the extract tests, the reference toxicant tests 
were conducted at pH 7. The test procedures were as described above 
with the stock Zn concentration determined by atomic absorption 
analysis. 
To facilitate ~omparison, the Zn concentration of each test 
dilution was normalized to 100 mg/L Caco3 hardness [17,18]. The 50% 
malformation and lethal concentrations [EC50(malformation) and LC50] 
were determined as mg/L Zn, using the TOXDAT Multi-method program [16]. 
In addition, the 50% effects concentrations for mortality and 
malformation in the reference toxicant tests were calculated using the 
Litchfield-Wilcoxon test [19]. The t-Test for grouped observations was 
used to determine the minimum concentration to inhibit growth (MCIG) in 
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each test (p=O.OS) [12]. All ECSO, LCSO, and MCIG values were 
determined after the Zn concentration of each dilution of the sediment 
extracts and reference toxicant had been normalized to 100 mg/L 
hardness. Therefore, all test results are presented in terms of 
normalized Zn concentration. Teratogenicity Index (TI) values were 
calculated for the reference toxicant tests [9]. 
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Results 
The measured Zn concentration in the undiluted sediment extract's 
ranged from 1.0 mg/L at pH 7 to 53.6 mg/L at pH 4 (Table VIII). Iron 
was the next most abundant metal detected in the extracts with a range 
from 2.1 to 13.0 mg/L. Trace levels of nickel, chromium, cadmium, 
arsenic, and selenium were detected in some extracts. No detectable 
quantities of lead or copper were found in any sample. Mean 
alkalinity and hardness values for the undiluted extract samples ranged 
from 62 to 1900 mg/L and 110 to 560 mg/L Caco3 , respectively. The 
dissolved oxygen content of the exposure solutions ranged from 6 to 8 
mg/L while the range for pH was 6.8 to 7.6 during the tests. 
The EC50(malformation) for fathead minnow embryo/larvae exposed to 
the sediment extracts ranged from 0.5 to 1.1 mg/L Zn (normalized 
concentrations), except for one pH 7 ~xtract with an EC50 of 1.4 mg/L 
Zn (Table IX). In two reference toxicant tests the EC50 values were 
0.6 and 0.8 mg/L Zn. The minimum concentration to inhibit growth 
(MCIG) for the extracts ranged from 0.4 to 1.6 mg/L Zn and were 0.6 and 
0.9 mg/L Zn in the reference toxicant tests. The 6 d LC50s for the pH 
4 and 5 extracts ranged from 1.5 to 2.2 mg/L Zn, however, 50% mortality 
was not obtained in the pH 6 and 7 extracts. The LC50 for the second 
reference toxicant test was 3.6 mg/L Zn, whereas the concentration 
range for the first test was not high enough to obtain an LC50. Control 
malformation was usually zero and never )10%. Mortality in the 
controls was always 5% or less. The concentration-response curves for 
malformation of fathead minnow embryos exposed to the sediment extracts 
and the reference toxicant (zinc sulfate) essentially overlapped. The 
concentration-response curves for the pH 5 extracts and the 
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reference toxicant appear in Figure 3. Curves for the other extracts 
were similar and are, therefore, not shown. 
The EC50 for frog embryos exposed to the sediment extracts ranged 
from 2.2 to 3.6 mg/L Zn and was 3.6 mg/L Zn for the reference toxicant 
test (Table IX). The MCIG was between 2.0 and 4.2 mg/L Zn for the 
extracts and was 4.2 mg/L Zn for the reference toxicant test. There 
was little or no mortality in the extracts after 4 d of exposure. The 
4 d LC50 for the reference toxicant test was 34.5 mg/L Zn. Control 
malformation and mortality was usually <5% and always <10%. The 
concentration-response curves for malformation of frog embryos exposed 
to the sediment extracts and the reference toxicant also essentially 
overlapped. The response curves for frog embryos exposed to the pH 5 
extracts and the reference toxicant appear in Figure 4. 
The malformation and mortality curves for the reference toxicant 
tests were in separate concentration ranges for both species (Fig.· 5). 
The Teratogenicity Index values [TI = LC50/EC50 (malformation)] were 
5.1 for fathead minnows and 9.6 for frogs. 
The types and severity of malformations observed in fathead minnow 
larvae were similar between the sediment extract and reference toxicant 
tests. The malformations were more severe with increasing Zn 
concentration. Below 0.5 mg/L Zn, abnormalities were mild kinking or 
edema which were also observed in some controls. Above 1 mg/L, gross 
malformations were observed: edema (gut, pericardial, and eye), 
kinking, fin abnormalities and blistering. At higher Zn concentrations 
the mouth was incompletely formed and hemorrhaging and cardiac 
abnormalities were noted. Some organisms did not hatch. All grossly 
malformed individuals were incapable of swimming normally, if at all. 
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Some premature hatching took place on days 3 and 4 at 1 to 4 mg/1 Zn. 
This did not appear to affect survival. Above 4 mg/1, membrane 
rupturing was often observed on days 1 and 2. These organisms appeared 
to be abnormal and soon died. 
The types and severity of malformations observed in frog larvae 
were also similar between the sediment extract and reference toxicant 
tests and the malformations were more severe with increasing Zn 
concentration. A noticeable increase in pericardia! edema and abnormal 
gut coiling occurred in frog embryos exposed to 2 to 5 mg/1 Zn. Above 
5 mg/1, skeletal kinking and edema in the dorsal fin were also 
observed. Above 8 mg/1 Zn, fin blistering and edema around the eyes 
were noted. There was also incomplete gut coiling, the mouth was 
improperly formed, and the size of the head, eye, and brain reduced. 
Above 20 mg/1 Zn, in the reference toxicant test, all tadpoles lacked 
proper pigmentation. Heart coiling was absent in some embryos. Facial 
and fin necrosis were noted in live tadpoles. Severely malformed 
organisms displayed a shaking movement, otherwise swimming behavior was 
absent. Animals that died appeared to be paralyzed before death. 
Thirty frog embryos that developed normally for 72 h in MFS were 
exposed to one extract from 72 to 96 h. All of these embryos had 
severe edema in the heart and gut regions at 96 h and gut coiling was 
halted. 
Fathead minnow and frog embryos showed no malformation or mortality 
above control levels after exposure to the chelated portion of an 
extract (Neosho River #1 pH 4). More than 99% of the zinc was removed 
by chelation, leaving an effective Zn concentration of 0.24 mg/1 
(normalized concentration) in the sample. When fathead minnow embryos 
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were exposed to the unchelated portion of this sample, all were dead 
at 48 h while all frog embryos were severely malformed by the end of 
the test. 
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Discussion 
The Teratogenicity Index (TI) values for the reference toxicant 
tests indicated Zn was teratogenic to the developing aquatic 
vertebrates [19]. The results suggested Zn was the major causative 
agent for the teratogenic effects observed in organisms exposed to the 
sediment extracts. Other metals present in the extracts may have 
interacted to affect developmental toxicity. Chelation, specific for 
divalent metal ions, removed )99% of the heavy metals and reduced 
malformation to control levels, therefore, organics were unlikely to 
have caused the malformations in the extract samples. 
The fathead minnow embryo 6 d LCSO for the pH 4 and 5 extracts were 
somewhat lower than that for the reference toxicant test. This 
indicated that another factor in addition to Zn toxicity was involved. 
The additional toxicity may have been due to one or more of the other 
metals in these extracts, possibly nickel. In contrast, 50% mortality 
was not observed i~ three pH 6 extracts with measured Zn concentrations 
above the reference toxicant LCSO for fathead minnow embryos (3.6 mg/L 
Zn). This lack of expected mortality can be explained by the effective 
Zn concentration of less than 3 mg/L in these samples after 
normalization for hardness. Similarly, the lack of frog embryo 
mortality in the pH 4 extracts can be explained by the effective Zn 
concentration of less than 16 mg/L in the samples after normalization. 
In the frog embryo reference toxicant test there was no mortality at 16 
mg/L Zn. 
The types of malformations in both test species were similar and 
increased in severity as Zn increased. In 67% of the tests in which 
effects were observed, the ECSO(malformation) was lower than the 
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minimum concentration to inhibit growth (MCIG), demonstrating the 
sensitivity of the malformation endpoint. Gross terata were easily 
detected using a dissecting microscope. Some malformations were 
obvious to the unaided eye. 
Thirty normally developing frog larvae exposed at 72 h to an 
extract sample with 12.5 mg/L Zn were all severely malformed 24 h 
later. This demonstrated that even a brief exposure to Zn during 
organogenesis was detrimental to the developing aquatic vertebrates. 
The sensitivity of the results in this study compare favorably with 
previous work. For example, in a 10 month chronic study using adult 
fathead minnows, Brungs demonstrated that reproduction was inhibited at 
as low as 0.1 mg/L Zn (concentration normalized to 100 mg/L hardness 
for comparison) [2]. In the present study, the no observed effects 
concentrations (NOEC) for malformation of fathead minnow embryos was 
0.12 mg/L Zn in the reference toxicant tests. The lowest observed 
effects concentration (LOEC) for malformation was 0.43 mg/L Zn. 
Therefore, the LOEC in our short-term study approached the LOEC for the 
10 month life cycle study. 
Brungs exposed eggs spawned in control water to Zn, although there 
was no mention of malformations, reported fry mortality after 20 d 
ex~osure was 2 to 12% at 0.37 mg/L and 51 to 70% at 0.73 mg/L Zn 
(concentrations normalized to 100 mg/1 hardness)[2]. In the present 
study, 20% of the fathead minnow embryos were malformed after 6 d 
exposure to 0.58 mg/1 Zn while 48% were malformed at 0.76 mg/1 Zn. Fry 
survivability would be impaired if abnormal development inhibited 
feeding and/or swimming abilities. 
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The Teratogenicity Index (TI) is a relative measure of the 
separation of the malformation and mortality curves [9]. The TI values 
obtained for Zn in this study (5.1 and 9.6 for fish and frog embryos, 
respectively) were relatively high [Dawson and Bantle, in press]. This 
indicated that the lowest Zn concentration needed to cause mortality of 
the embryos was approximately 5 to 10 times greater than the lowest 
concentration needed to produce malformations. In contrast to Zn, the 
TI for Cd in frog embryos was 1.3 [10], indicative of a small 
separation of the malformation and mortality curves. In published Zn 
and Cd life cycle studies using fathead minnows, a similar pattern was 
apparent for the separation of the reproductive inhibition and 
mortality curves. For Zn, the lowest concentration necessary to cause 
mortality in adults was more than 10 times greater than the lowest 
concentration needed to inhibit reproduction [2]. For Cd, the lowest 
concentration necessary to cause mortality was less than 2 times 
greater than that needed to inhibit reproduction [3]. Further tests 
evaluating gross terata, reproductive inhibition, and mortality are 
needed to determine if there is a consistent relationship between these 
parameters. If so, the malformation endpoint and TI of FETAX used in 
this investigation may prove useful for rapidly determining sublethal 
effects levels of aqueous contaminants. 
The mechanism of Zn teratogenicity is presently unknown although 
the inhib{tion of DNA synthesis by excess Zn is the most likely 
explanation. Zinc is a cofactor for many enzymes such as DNA 
polymerase and thymidine kinase [20]. Due to this requirement, a 
slight increase in Zn concentration can stimulate DNA synthesis while a 
large deficiency or excess leads to an inhibition of DNA synthesis 
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[21]. DNA synthesis inhibitors have proven to be teratogenic in a 
variety of ani~als regardless of their mode of action [22-23]. Zinc 
deficiency is clearly teratogenic in mammals while Zn excess seems to 
be less teratogenic [24-25]. This may be due to the action of maternal 
liver and placental metallothioneins which prevent excess Zn from 
disrupting embryonic DNA synthesis. Oviparous aquatic organisms would 
not receive such protection and would likely be more sensitive to large 
excesses of Zn, causing abnormal development. In this study, the 
relatively large TI values and severity of the malformations in the Zn 
reference toxicant tests were consistent with previous FETAX studies in 
which known DNA synthesis inhibitors were tested [22]. Further tests 
are needed to more fully evaluate DNA synthesis inhibition as the 
mechanism for Zn teratogenicity. 
The potential toxicity of the sediments tested in this study 
related primarily to the effective Zn concentration in the extracts. 
Therefore, the acid-extraction technique for metal-contaminated aquatic 
sediments [13] appears to be useful for evaluating potential toxicity 
in the event metals are released from aquatic sediments due to dredging 
or acidification. 
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Table VIII. Metals content,a alkalinity, and hardness of the undiluted sample extracts. 
Sediment Extracts Zn Fe Ni Cr Cd As Se b b Alk. Hard. 
pH 7 extracts 
Tar Creek lfl 1.7 7.06 <O .13 0.010 (0.005 0.035 0.011 83 110 
Neosho River ltl 1.0 7.62 0.13 0.012 (0.005 0.025 0.010 62 151 
pH 6 extracts 
Tar Creek ltl 4.4 7.05 (0.13 0.007 (0.005 0.014 0.011 95 167 
Tar Creek lf2 4.6 5.24 (0.13 0.008 (0.005 (0.005 0.016 49 175 
Neosho River ttl 4.1 4.44 (0.13 (0.005 (0.005 (0.005 0.010 111 215 
Neosho River tf2 2.4 4.96 (0.13 0.008 (0.005 (0.005 0.016 95 205 
pH 5 extracts 
Tar Creek ttl 16.0 4.10 0.19 (0.005 (0.005 0.005 0.009 153 373 
Tar Creek lt2 16.2 2.07 0.20 (0.005 (0.005 (0.005 0.016 206 287 
Neosho River ttl 14.6 3.16 0.18 0.006 (0.005 0.005 0.013 239 354 
Neosho River tf2 12.0 4.95 0.16 (0.005 (0.005 (0.005 0.013 229 319 
Table VIII. cont. 
--
pH 4 extracts 
Tar Creek Ill 53.6 10.49 0.66 (0.005 0.025 0.010 0.029 1280 453 
Tar Creek 112 53.2 12.96 0.70 (0.005 0.029 0.012 0.049 1460 515 
Neosho River lil 48.3 5.02 0.58 (0.005 0.060 0.017 0.036 1700 510 
Neosho River 112 45.7 6.36 0.59 (0.005 0.036 0.017 0.042 1900 560 
Neosho River chelatedc 0.4 (0.05 (0.13 (0.005 <0.005 0.020 0.040 1490 182 
a Values are mg/L as determined by atomic absorption analysis. 
b Alk. -alkalinity, Hard. -hardness: Mean value of undiluted extracts, expressed as mg/L Caco3 • 
c Sample was passed over Chelex-100, a bound ion-exchange resin, to remove heavy metal ions. 
Table IX. Malformation, growth, and mortality responses of fish and frog embryos in the extract and 
zinc tests. 
FATHEAD MINNOW FROG 
Samples EC50a(95%CI) MCIGb LC50 (95%CI) EC50a(95%CI) MCIGb LC50 (95%CI) 
(mg/L Zn - normalized to 100 mg/L hardness) 
pH 7 extracts 
Tar Creek Ill 1.4 (+1.4) 1.6 c 
Neosho River Ill 
pH 6 extracts 
Tar Creek Ill 0.8 (+0.3) 1.1 --- --- 2.9 
Tar Creek 112 0.7 (±_0.3) 1.1 --- 2.8 (+0.2) 2.9 
Neosho River Ill 0.9 (±_0.4) 0.9 --- --- 2.0 
Neosho River 112 1.1 (+1.1) 0.8 
pH 5 extracts 
Tar Creek Ill 0.7 (+0.2) 1.2 1.6 (±_{) .6) 2.7 (±_0.5) 2.8 
Tar Creek 112 0.8 (+0.4) 1.4 2.2 (±_0.8) 3.3 (±_0.5) 2.4 
Neosho River Ill 0.6 (±_0.2) 1.1 1.3 (±_{). 7) 2.5 (±_0.5) 3.2 
Neosho River 112 0.5 (+0.4) 1.0 1.6 (±_{). 7) 2.5 (±_0.3) 2.3 
Table IX. cont. 
--
pH 4 extracts 
Tar Creek lfl 0.8 0.5 1.7 (+1.0) 3.2 (+1.0) 3.9 
Tar Creek 112 0 • 6 (_±(). 6) 1.4 1.5 (+1.5) 3.5 (_±1.0) 3.8 
Neosho River Ill 0.5 (+0.5) 0.4 2.1 (+1.2) 2.9 (+1.2) 3.4 
Neosho River 112 0.8 (+0.4) 1.2 2.1 (+1.0) 3.6 (_±0.7) 4.2 
Zinc 
--
Zinc Sulfate Ill 0.6 (+0.6) 0.9 --- 3.6 (+0.5) 4.2 34.5 (+1. 2) 
Zinc Sulfate 112 0.8 (_±{) .3) 0.6 3.6 (+0.9) 
a EC50 for malformation only, values are for 6 d tests for fathead minnow and 4 d tests for frog embryos. 
b Minimum concentration to inhibit growth (p=0.05). 
c --- indicates 50% effect not obtained or growth not inhibited. 
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Figure Legends 
Figure 3. Zinc concentration-response curves for malformation of 
fathead minnow embryos exposed for 6 d to Tar Creek and Neosho River 
sediments extracted at pH 5 (Exp #1 = first extract exposure, Exp #2 = 
second extract exposure) and the zinc sulfate reference toxicant. 
Tests were conducted at pH 7. 
Figure 4. Zinc concentration-response curves for malformation of frog 
embryos exposed for 4 d to Tar Creek and Neosho River sediments 
extracted at pH 5 (Exp #1 = first extract exposure, Exp #2 = second 
extract exposure) and the zinc sulfate reference toxicant. Tests were 
conducted at pH 7. 
Figure 5. Concentration-response curves for malformation and mortality 
of fathead minnow and frog embryos exposed for 6 and 4 d, respectively, 
to the zinc sulfate reference toxicant. Tests were conducted at pH 7. 
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